ANG Lifesciences India Limited held its board meeting on September 7, 2026, to approve the re-appointment of key directors and fix the date for its upcoming annual general meeting.

The board approved the proposal to re-appoint Mr. Rohit Mittal, who is due to retire by rotation under Section 152(6) of the Companies Act, 2013. His re-appointment will be placed before shareholders for approval at the ensuing AGM.

Board Approvals and AGM Details

The board fixed the date for the 20th Annual General Meeting (AGM) as September 30, 2026, at 12:00 pm. The meeting will be conducted through Video Conference or Other Audio-Visual Mode (VC/OAVM).

Key logistical details for the AGM include:

• Book Closure Period: September 24, 2026, to September 30, 2026 (both days inclusive).
• Cut-off Date: September 23, 2026, for determining members eligible to vote on resolutions.
• Scrutinizer: M/s Anil Negi & Company, Practicing Company Secretary, was appointed to scrutinize e-voting.

The board also considered and approved the appointment of M/s Shreya Sahu & Associates (FRN 101389) as Cost Auditor for FY27. Additionally, the board approved the Board’s report along with annexures for FY26.

Director Re-appointment

Based on the recommendation of the Nomination and Remuneration Committee, the board approved the re-appointment of Mrs. Chetna (DIN: 08981045) as an Independent Director. This marks her second term, which will run for five consecutive years from October 12, 2026, to October 11, 2031, subject to shareholder approval.

Mrs. Chetna holds an LLB from Jaipur School of Law, is a Company Secretary from the Institute of Company Secretaries of India, and holds an MBA in Finance. She is registered in the Independent Director Databank under the Indian Institute of Corporate Affairs with registration number IDDB-PA-202012-032734. The disclosure confirms no relationship exists between her and other Directors or Key Managerial Personnel.

ANG Lifesciences India Ltd has closed its trading window for insiders, designated persons, and their immediate relatives effective July 1, 2026. The closure is enforced to comply with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct. The window will remain shut until 48 hours after the declaration of the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

The company has advised all designated persons and their immediate relatives to refrain from trading in the company's securities during this closure period. This measure is intended to prevent insider trading and ensure market integrity during the sensitive period surrounding financial results.

Regulatory Compliance

The trading window closure is a standard procedure implemented ahead of quarterly financial announcements. It aligns with the requirements set forth by the Securities and Exchange Board of India (SEBI) under the Prohibition of Insider Trading Regulations.

Key Dates and Details

The board meeting to consider the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, will be announced at a later date. The filing was signed by Rajesh Gupta, Managing Director.